Montreal, Canada and London, UK, February 20, 2019
The NEOMED Institute (NEOMED), GlaxoSmithKline Inc. (GSK), the Centre Hospitalier de l'Université de Montréal (CHUM) Research Centre and University College London (UCL) are pleased to announce that they have entered into a strategic collaboration to explore the potential of a
MONTRÉAL, Dec. 7, 2018 - The City of Montréal and the Government of Canada announced today their financial support for the NEOMED Institute for the implementation of a new innovation and commercialization complex (ICC), specializing in life sciences and health technology (LSHT). This complex will provide SMEs with customized labs, shared equi
Montreal, Quebec, November 14, 2018 – NEOMED Institute announced today that experienced bio-pharmaceutical scientist and executive Dr. Youssef Bennani has joined its Board of Directors.
Dr. Youssef Bennani is currently Chairman of the Board of Domain Therapeutics (France & Canada), and is an independent Board member of
LAVAL, QC. and WELLESLEY, MA., September 4, 2018 – Ampersand Capital Partners, together with the management team of NEOMED-LABS and the NEOMED Institute, announced today that Ampersand has partnered with management in the acquisition of NEOMED-LABS from its not-for-profit founder and parent, the NEOMED Institute.